Clinical Characteristics and Associations of the "Good Fontan" Patient
1 other identifier
observational
146
1 country
1
Brief Summary
This study aims to determine what are some of the clinical characteristics and associations of Fontan patients who are doing well, as well as how accurate cardiology providers are at predicting the likelihood of future adverse event in their Fontan patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2018
CompletedFirst Submitted
Initial submission to the registry
March 6, 2018
CompletedFirst Posted
Study publicly available on registry
March 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2023
CompletedApril 19, 2023
April 1, 2023
5 years
March 6, 2018
April 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surprise question
The ability of the cardiologist's response to the "surprise" question to predict adverse cardiac events within 1 year
1 year
Secondary Outcomes (3)
Clinical characteristics and associations of the "good Fontan"
1 year
Correlation between patient and provider assessments
1 year
Clinician factors associated with adverse events conversation with patients
1 year
Study Arms (2)
Pediatric Fontan Patients
Participants ages 10 to 18 who have had Lateral Tunnel or Extracardiac Fontan procedures.
Adult Fontan Patients
Participants ages 18 to 60 who have had Lateral Tunnel or Extracardiac Fontan procedures.
Eligibility Criteria
Patients with congenital heart disease who have undergone the Fontan procedure.
You may qualify if:
- Extracardiac or Lateral Funnel Fontan
You may not qualify if:
- Currently being evaluated for or listed for cardiac transplant
- Underwent Fontan revision or conversion
- Currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- New England Congenital Cardiology Association (NECCA)collaborator
- Yale Universitycollaborator
- Dartmouth Collegecollaborator
- Connecticut Children's Medical Centercollaborator
- University of Vermontcollaborator
- Child Heart Associatescollaborator
- Congenital Heartcollaborator
- University of Massachusetts, Worcestercollaborator
- Massachusetts General Hospitalcollaborator
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Related Publications (5)
d'Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation. 2007 Sep 11;116(11 Suppl):I157-64. doi: 10.1161/CIRCULATIONAHA.106.676445.
PMID: 17846297BACKGROUNDDiller GP, Giardini A, Dimopoulos K, Gargiulo G, Muller J, Derrick G, Giannakoulas G, Khambadkone S, Lammers AE, Picchio FM, Gatzoulis MA, Hager A. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J. 2010 Dec;31(24):3073-83. doi: 10.1093/eurheartj/ehq356. Epub 2010 Oct 7.
PMID: 20929979BACKGROUNDBlume ED, Balkin EM, Aiyagari R, Ziniel S, Beke DM, Thiagarajan R, Taylor L, Kulik T, Pituch K, Wolfe J. Parental perspectives on suffering and quality of life at end-of-life in children with advanced heart disease: an exploratory study*. Pediatr Crit Care Med. 2014 May;15(4):336-42. doi: 10.1097/PCC.0000000000000072.
PMID: 24583501BACKGROUNDLakin JR, Robinson MG, Bernacki RE, Powers BW, Block SD, Cunningham R, Obermeyer Z. Estimating 1-Year Mortality for High-Risk Primary Care Patients Using the "Surprise" Question. JAMA Intern Med. 2016 Dec 1;176(12):1863-1865. doi: 10.1001/jamainternmed.2016.5928. No abstract available.
PMID: 27695853BACKGROUNDHamano J, Morita T, Inoue S, Ikenaga M, Matsumoto Y, Sekine R, Yamaguchi T, Hirohashi T, Tajima T, Tatara R, Watanabe H, Otani H, Takigawa C, Matsuda Y, Nagaoka H, Mori M, Yamamoto N, Shimizu M, Sasara T, Kinoshita H. Surprise Questions for Survival Prediction in Patients With Advanced Cancer: A Multicenter Prospective Cohort Study. Oncologist. 2015 Jul;20(7):839-44. doi: 10.1634/theoncologist.2015-0015. Epub 2015 Jun 8.
PMID: 26054631BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rahul Rathod, MD
Boston Children's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiologist
Study Record Dates
First Submitted
March 6, 2018
First Posted
March 20, 2018
Study Start
March 5, 2018
Primary Completion
March 20, 2023
Study Completion
April 18, 2023
Last Updated
April 19, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share